arrow
I

Ivan Fan-Ngai Hung

University of Hong Kong
H指数:70
被引数:2.5万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Antibiotic stewardship in suspected neutropenic fever (ASTERIC trial): a multicentre, type 1 hybrid effectiveness-implementation, stepped-wedge, randomised controlled trial study protocol

抗菌药物合理使用在疑似中性粒细胞减少性发热中的应用(ASTERIC试验):一项多中心、I型混合效果-实施、阶梯式楔形随机对照试验研究方案

2025-11-240
OA
Disease Pattern, Risk factors of Antimicrobial Resistance in Patients with Pneumococcal Infection in Hong Kong Population

肺炎链球菌感染在香港人群中的疾病模式及抗菌药物耐药风险因素

2025-10-300
OAAI
Comparative Effectiveness of Combination Therapy with Nirmatrelvir-Ritonavir and Molnupiravir versus Monotherapy with Molnupiravir or Nirmatrelvir-Ritonavir in Hospitalised COVID-19 Patients: A Target Trial Emulation Study

纳马特雷韦-利托那韦联合疗法与莫诺拉韦单药疗法或纳马特雷韦-利托那韦单药疗法在住院COVID-19患者中的比较有效性:一项目标试验模拟研究

2025-10-030
OAAI
Post-COVID-19 multimorbidity incidence by prior vaccination status in people with a pre-existing comorbidity: A population-based cohort study

后COVID-19时期,在存在预存合并症的人群中,根据既往疫苗接种状态分析多病共存发生率:一项基于人群的队列研究

2025-08-210
OAAI
The Editorial

《编辑意见》

VACCINE
IF3.5
2025-01-010
PRE
Sex differences in association between gut microbiome and 24-hour blood pressure variability
2024-09-010
PRE
The impact of vaccine type and booster dose on the magnitude and breadth of SARS-CoV-2-specific systemic and mucosal antibodies among COVID-19 vaccine recipients

疫苗类型和加强剂量对新型冠状病毒肺炎疫苗接种者全身和粘膜抗体SARS-CoV-2-specific的幅度和广度的影响

HELIYON
IF3.6
2024-08-010
OAAI